MedPath

ELI LILLY AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

68

TGA:68

Drug Approvals

OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection autoinjector (pre-filled pen) composite pack (citrate-free formulation) (461105)

Product Name
OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection autoinjector (pre-filled pen) composite pack (citrate-free formulation)
Approval Date
Jul 4, 2025
TGA

OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe (citrate-free formulation) (461088)

Product Name
OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe (citrate-free formulation)
Approval Date
Jul 4, 2025
TGA

OMVOH mirikizumab 100 mg/mL solution for injection autoinjector (pre-filled pen) (citrate-free formulation) (461045)

Product Name
OMVOH mirikizumab 100 mg/mL solution for injection autoinjector (pre-filled pen) (citrate-free formulation)
Approval Date
Jul 4, 2025
TGA

OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation) (461265)

Product Name
OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation)
Approval Date
Jul 4, 2025
TGA

KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial (420194)

Product Name
KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial
Approval Date
May 21, 2025
TGA

TALTZ ixekizumab 80 mg/mL solution for injection prefilled syringe (414413)

Product Name
TALTZ ixekizumab 80 mg/mL solution for injection prefilled syringe
Approval Date
Aug 15, 2024
TGA

TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen (414414)

Product Name
TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen
Approval Date
Aug 15, 2024
TGA

MOUNJARO KwikPen tirzepatide 20.83 mg/mL solution for injection multidose pre-filled pen (439693)

Product Name
MOUNJARO KwikPen tirzepatide 20.83 mg/mL solution for injection multidose pre-filled pen
Approval Date
Jun 19, 2024
TGA

MOUNJARO KwikPen tirzepatide 8.33 mg/mL solution for injection multidose pre-filled pen (439690)

Product Name
MOUNJARO KwikPen tirzepatide 8.33 mg/mL solution for injection multidose pre-filled pen
Approval Date
Jun 19, 2024
TGA

MOUNJARO KwikPen tirzepatide 12.5 mg/mL solution for injection multidose pre-filled pen (439691)

Product Name
MOUNJARO KwikPen tirzepatide 12.5 mg/mL solution for injection multidose pre-filled pen
Approval Date
Jun 19, 2024
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.